Effects of FTO RS9939906 and MC4R RS17782313 on obesity, type 2 diabetes mellitus and blood pressure in patients with hypertension

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Marcadenti, Aline ^a   Fuchs, Flavio D ^a,b   Matte, Ursula ^b   Sperb, Fernanda ^b   Moreira, Leila B ^a,b   Fuchs, Sandra C ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Body mass index; Diabetes mellitus; FTO rs9939609; Hypertension; Lipid Accumulation Product index; MC4R rs17782313; Neck circumference; Waist circumference

Indexed keywords

ADULT; ARTICLE; BODY MASS; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FTO GENE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTENSION; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; MC4R GENE; MEAN ARTERIAL PRESSURE; NECK CIRCUMFERENCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; AGE; AGED; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PATHOPHYSIOLOGY; PHENOTYPE; RISK FACTOR; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

FTO PROTEIN, HUMAN; MC4R PROTEIN, HUMAN; MELANOCORTIN 4 RECEPTOR; PROTEIN;

ADIPOSITY; AGE FACTORS; AGED; BLOOD PRESSURE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; RECEPTOR, MELANOCORTIN, TYPE 4; RISK FACTORS; SEX FACTORS; WAIST CIRCUMFERENCE;

EID: 84880011205     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-103     Document Type: Article

References (45)

1. Tuck ML, Corry DB. Prevalence of obesity, hypertension, diabetes, and metabolic syndrome and its cardiovascular complications. Curr Hypertens Rev 2010, 6:73-82.
2. Rankinen T, Zuberi A, Chagnon YC, Weisnagel SJ, Argyropoulos G, Walts B, Pérusse L, Bouchard C. The human obesity gene map: the 2005 update. Obesity (Silver Spring) 2006, 14:529-644.
3. Van der Hoeven F, Schimmang T, Volkmann A, Mattei MG, Kyewski B, Ruther U. Programmed cell death is affected in the novel mouse mutant Fused toes (Ft). Development 1994, 120:2601-2607.
4. Cecil JE, Tavendale R, Watt P, Hetherington MM, Palmer CN. An obesity-associated FTO gene variant and increased energy intake in children. N Engl J Med 2008, 359:2558-2566. 10.1056/NEJMoa0803839, 19073975.
5. Wardle J, Carnell S, Haworth CMA, Farooqi SI, O'Rahilly S, Plomin R. Obesity-associated genetic variation in FTO associated with diminished satiety. J Clin Endocrinol Metab 2008, 93:3640-3643. 10.1210/jc.2008-0472, 18583465.
6. Vaisse C, Clement K, Guy-Grand B, Froguel P. A frameshift mutation in MC4R is associated with a dominant form of obesity. Nature Genet 1998, 20:113-114. 10.1038/2407, 9771699.
7. Farooqi IS, Keogh JM, Yeo GSH, Lank EJ, Cheetham T, O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003, 348:1085-1095. 10.1056/NEJMoa022050, 12646665.
8. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, Perry JR, Elliott KS, Lango H, Rayner NW, Shields B, Harries LW, Barrett JC, Ellard S, Groves CJ, Knight B, Patch AM, Ness AR, Ebrahim S, Lawlor DA, Ring SM, Ben-Shlomo Y, Jarvelin MR, Sovio U, Bennett AJ, Melzer D, Ferrucci L, Loos RJ, Barroso I, Wareham NJ, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007, 316:889-893. 10.1126/science.1141634, 2646098, 17434869.
9. Loos RJ, Lindgren CM, Li S, Wheeler E, Zhao JH, Prokopenko I, Inouye M, Freathy RM, Attwood AP, Beckmann JS, Berndt SI, Jacobs KB, Chanock SJ, Hayes RB, Bergmann S, Bennett AJ, Bingham SA, Bochud M, Brown M, Cauchi S, Connell JM, Cooper C, Smith GD, Day I, Dina C, De S, Dermitzakis ET, Doney AS, Elliott KS, Elliott P, et al. Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet 2008, 40:768-775. 10.1038/ng.140, 2669167, 18454148, Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
10. Kring SI, Holst C, Zimmermann E, Jess T, Berentzen T, Toubro S, Hansen T, Astrup A, Pedersen O, Sørensen TI. FTO gene associated fatness in relation to body fat distribution and metabolic traits throughout a broad range of fatness. PLoS One 2008, 3:e2958. 10.1371/journal.pone.0002958, 2493033, 18698412.
11. Ramos RB, Casanova GK, Maturana MA, Spritzer PM. Variations in the fat mass and obesity-associated (FTO) gene are related to glucose levels and higher lipid accumulation product in postmenopausal women from southern Brazil. Fertil Steril 2011, 96:974-979. 10.1016/j.fertnstert.2011.07.1148, 21868005.
12. Liu G, Zhu H, Lagou V, Gutin B, Barbeau P, Treiber FA, Dong Y, Snieder H. Common variants near melanocortin 4 receptor are associated with general and visceral adiposity in European- and African-American youth. J Pediatr 2010, 156:598-605. 10.1016/j.jpeds.2009.10.037, 20070976.
13. Li H, Kilpeläinen TO, Liu C, Zhu J, Liu Y, Hu C, Yang Z, Zhang W, Bao W, Cha S, Wu Y, Yang T, Sekine A, Choi BY, Yajnik CS, Zhou D, Takeuchi F, Yamamoto K, Chan JC, Mani KR, Been LF, Imamura M, Nakashima E, Lee N, Fujisawa T, Karasawa S, Wen W, Joglekar CV, Lu W, Chang Y, et al. Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. Diabetologia 2012, 55:981-995. 10.1007/s00125-011-2370-7, 3296006, 22109280.
14. Qi L, Kraft P, Hunter DJ, Hu FB. The common obesity variant near MC4R gene is associated with higher intakes of total energy and dietary fat, weight change and diabetes risk in women. Hum Mol Genet 2008, 17:3502-3508. 10.1093/hmg/ddn242, 2572696, 18697794.
15. Tschritter O, Haupt A, Preissl H, Ketterer C, Hennige AM, Sartorius T, Machicao F, Fritsche A, Häring HU. An obesity risk SNP (rs17782313) near the MC4R gene is associated with cerebrocortical insulin resistance in humans. J Obes 2011, 2011:283153. 3136179, 21773004.
16. Pausova Z, Syme C, Abrahamowicz M, Xiao Y, Leonard GT, Perron M, Richer L, Veillette S, Smith GD, Seda O, Tremblay J, Hamet P, Gaudet D, Paus T. A common variant of the FTO gene is associated with not only increased adiposity but also elevated blood pressure in French Canadians. Circ Cardiovasc Genet 2009, 2:260-269. 10.1161/CIRCGENETICS.109.857359, 20031594.
17. Gerken T, Girard CA, Tung YC, Webby CJ, Saudek V, Hewitson KS, Yeo GS, McDonough MA, Cunliffe S, McNeill LA, Galvanovskis J, Rorsman P, Robins P, Prieur X, Coll AP, Ma M, Jovanovic Z, Farooqi IS, Sedgwick B, Barroso I, Lindahl T, Ponting CP, Ashcroft FM, O'Rahilly S, Schofield CJ. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 2007, 318:1469-1472. 10.1126/science.1151710, 2668859, 17991826.
18. Schmid PM, Heid I, Buechler C, Steege A, Resch M, Birner C, Endemann DH, Riegger GA, Luchner A. Expression of fourteen novel obesity-related genes in zucker diabetic fatty rats. Cardiovasc Diabetol 2012, 11:48-59. 10.1186/1475-2840-11-48, 3398851, 22553958.
19. Guyenet PG. The sympathetic control of blood pressure. Nat Ver Neurosci 2006, 7:335-346.
20. Cone RD. The central melanocortin system and energy homeostasis. Trends Endocrinol Metab 1999, 10:211-216. 10.1016/S1043-2760(99)00153-8, 10407394.
21. Greenfield JR, Miller JW, Keogh JM, Henning E, Satterwhite JH, Cameron GS, Astruc B, Mayer JP, Brage S, See TC, Lomas DJ, O'Rahilly S, Farooqi IS. Modulation of blood pressure by central melanocortinergic pathways. N Engl J Med 2009, 360:44-52. 10.1056/NEJMoa0803085, 19092146.
22. Timpson NJ, Harbord R, Davey Smith G, Zacho J, Tybjaerg-Hansen A, Nordestgaard BG. Does greater adiposity increase blood pressure and hypertension risk? Mendelian randomization using the FTO /MC4R genotype. Hypertension 2009, 54:84-90. 10.1161/HYPERTENSIONAHA.109.130005, 19470880.
23. Ortega-Azorín C, Sorlí JV, Asensio EM, Coltell O, Martínez-González M, Salas-Salvadó J, Covas MI, Arós F, Lapetra J, Serra-Majem L, Gómez-Gracia E, Fiol M, Sáez-Tormo G, Pintó X, Muñoz MA, Ros E, Ordovás JM, Estruch R, Corella D. Associations of the FTO rs9939609 and the MC4R rs17782313 polymorphisms with type 2 diabetes are modulated by diet, being higher when adherence to the Mediterranean diet pattern is low. Cardiovasc Diabetol 2012, 11:137-149. 10.1186/1475-2840-11-137, 3495759, 23130628.
24. Thomsen M, Dahl M, Tybjærg-Hansen A, Nordestgaard BG. β2-adrenergic receptor Thr164Ile polymorphism, obesity, and diabetes: comparison with FTO, MC4R, and TMEM18 polymorphisms in more than 64,000 individuals. J Clin Endocrinol Metab 2012, 97:1074-1079.
25. Marcadenti A, Fuchs SC, Moreira LB, Wiehe M, Gus M, Fuchs FD. Accuracy of anthropometric indexes of obesity to predict diabetes mellitus type 2 among men and women with hypertension. Am J Hypertens 2011, 24:175-180. 10.1038/ajh.2010.212, 20885370.
26. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ. Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research Recommendations for blood pressure measurement in humans and experimental animals. Part 1: Blood pressure measurement in humans - a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure. Hypertension 2005, 45:142-161. Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research.
27. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42:1206-1252. 10.1161/01.HYP.0000107251.49515.c2, 14656957, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee.
28. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2012, 35(Suppl 1):S64-S71. 3632174, 22187472, American Diabetes Association.
29. Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003, 35:1381-1395. 10.1249/01.MSS.0000078924.61453.FB, 12900694.
30. Bergman RN, Stefanovski D, Buchanan TA, Sumner AE, Reynolds JC, Sebring NG, Xiang AH, Watanabe RM. A better index of body adiposity. Obesity 2011, 19:1083-1089. 10.1038/oby.2011.38, 3275633, 21372804.
31. Kahn HS. The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord 2005, 5:26-36. 10.1186/1471-2261-5-26, 1236917, 16150143.
32. Winter Y, Sankowski R, Back T. Genetic determinants of obesity and related vascular diseases. Vitam Horm 2013, 91:29-48.
33. Jacobsson JA, Risérus U, Axelsson T, Lannfelt L, Schiöth HB, Fredriksson R. The common FTO variant rs9939609 is not associated with BMI in a longitudinal study on a cohort of Swedish men born 1920-1924. BMC Med Genet 2009, 10:131-139. 10.1186/1471-2350-10-131, 2797506, 20003232.
34. Jacobsson JA, Almén MS, Benedict C, Hedberg LA, Michaëlsson K, Brooks S, Kullberg J, Axelsson T, Johansson L, Ahlström H, Fredriksson R, Lind L, Schiöth HB. Detailed analysis of variants in FTO in association with body composition in a cohort of 70-year-olds suggests a weakened effect among elderly. PLoS One 2011, 6:e20158. 10.1371/journal.pone.0020158, 3103532, 21637715.
35. Preis SR, Massaro JM, Hoffmann U, D'Agostino RB, Levy D, Robins SJ, Meigs JB, Vasan RS, O'Donnell CJ, Fox CS. Neck circumference as a novel measure of cardiometabolic risk: The Framingham Heart Study. J Clin Endocrinol Metab 2010, 95:3701-3710. 10.1210/jc.2009-1779, 2913042, 20484490.
36. Mangge H, Renner W, Almer G, Weghuber D, Möller R, Horejsi R. Rs9939609 variant of the fat mass and obesity-associated gene and trunk obesity in adolescents. J Obes 2011, 2011:186368. 3026980, 21318054.
37. Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD. Splanchnic lipolysis in human obesity. J Clin Invest 2004, 113:1582-1588. 419492, 15173884.
38. Cheung CY, Tso AW, Cheung BM, Xu A, Ong KL, Law LS, Wat NM, Janus ED, Sham PC, Lam KS. Genetic variants associated with persistent central obesity and the metabolic syndrome in a 12-year longitudinal study. Eur J Endocrinol 2011, 164:381-388. 10.1530/EJE-10-0902, 21147891.
39. Povel CM, Boer JM, Onland-Moret NC, Dollé ME, Feskens EJ, Van der Schouw YT. Single nucleotide polymorphisms (SNPs) involved in insulin resistance, weight regulation, lipid metabolism and inflammation in relation to metabolic syndrome: an epidemiological study. Cardiovasc Diabetol 2012, 11:133-142. 10.1186/1475-2840-11-133, 3507796, 23101478.
40. Parikh M, Hetherington J, Sheth S, Seiler J, Ostrer H, Gerhard G, Wood C, Still C. Frequencies of obesity susceptibility alleles among ethnically and racially diverse bariatric patient populations. Surg Obes Relat Dis 2012, 9:436-411. 3685296, 22695173.
41. Wu C, Gong Y, Yuan J, Gong H, Zou Y, Ge J. Identification of shared genetic susceptibility locus for coronary artery disease, type 2 diabetes and obesity: a meta-analysis of genome-wide studies. Cardiovasc Diabetol 2012, 11:68-79. 10.1186/1475-2840-11-68, 3481354, 22697793.
42. Robiou-du-Pont S, Bonnefond A, Yengo L, Vaillant E, Lobbens S, Durand E, Weill J, Lantieri O, Balkau B, Charpentier G, Marre M, Froguel P, Meyre D. Contribution of 24 obesity-associated genetic variants to insulin resistance, pancreatic beta-cell function and type 2 diabetes risk in the French population. Int J Obes (Lond) 2012, 37:980-985.
43. Kuo JJ, Da Silva AA, Hall JE. Hypothalamic melanocortin receptors and chronic regulation of arterial pressure and renal function. Hypertension 2003, 41:768-774. 10.1161/01.HYP.0000048194.97428.1A, 12623994.
44. Yamada Y, Tsuboi K, Hattori T, Murase T, Ohtake M, Furukawa M, Ueyama J, Nishiyama A, Murohara T, Nagata K. Mechanism underlying the efficacy of combination therapy with losartan and hydrochlorothiazide in rats with salt-sensitive hypertension. Hypertens Res 2011, 34:809-816. 10.1038/hr.2011.34, 21471973.
45. Williams MJ, Almén MS, Fredriksson R, Schiöth HB. What model organisms and interactomics can reveal about the genetics of human obesity. Cell Mol Life Sci 2012, 69:3819-3834. 10.1007/s00018-012-1022-5, 22618246.